Меню
Идёт набор NCT05789485

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

Фаза II С лечением Gastrointestinal Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: structured treadmill walking.
Кому может быть актуально
Состояния в реестре: Gastrointestinal Cancer. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Dose-response of Aerobic Training During Chemotherapy for Gastrointestinal Cancers

Обзор

The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the side effects of therapy. The study will also look at the way the body responds to exercise and whether there are differences in treatment. This will include looking at the highest treatment dose participants receive, how many people stop, delay, or reduce the treatment, and whether additional medication is needed to treat side effects of therapy.

Подробное описание

Study staff will also confirm remote training feasibility including items such as access to Wi-Fi and a treadmill for the study duration. If patients do not have access to a treadmill, ExOnc staff may coordinate access to a fitness facility local to the participant, to facilitate treadmill access for the study duration. Fitness facility access will be provided through Wellhub, a service that allows use of nearby gyms and studios through a single app-based solution.

Вмешательства

  • Поведенческое structured treadmill walking
    Three doses of AT (i.e., 90, 150, or 300 mins/week) will be tested. All doses will consist of individualized walking delivered up to 7 times per week delivered throughout treatment.

Первичные конечные точки

  • proportion of patients achieving (ratio of delivered to planned treatment) RDI ≥ 90% [Срок оценки: 5 years]

Критерии участия

Критерии включения

  • Aged ≥18 years
  • Diagnosed with colorectal or esophago/gastric solid tumors as defined by one of the following:
  • Histological confirmation
  • As per standard of care imaging
  • Scheduled to receive neoadjuvant chemotherapy or chemotherapy for newly diagnosed metastatic disease
  • Performing ≤90 minutes of structured moderate-intensity or strenuous-intensity exercise per week, as evaluated by self-report
  • Willingness to comply with all study-related procedures
  • Cleared for exercise participation as per screening clearance via the Physical Activity Readiness Questionnaire

Критерии исключения

  • Enrollment onto any other lifestyle interventional investigational study, except interventions determined by the PI not to confound study outcomes
  • Receiving treatment for any other diagnosis of invasive cancer
  • Mental impairment leading to inability to cooperate
  • Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Двойное слепое
Основная цель
Поддерживающая терапия

Центры проведения

США · 8 центров
  • Hartford Healthcare Alliance (Data Collection Only) — Hartford
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) — Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) — Montvale
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) — Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) — Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities) — Rockville Centre

Идентификаторы

NCT: NCT05789485 · 22-164

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗